Vision rehab and depression in age-related macular degeneration
Part of Eyes & vision, Mental health clinical trials.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years of age or older.
- You have moderate to severe vision loss (visual acuity between 1/10 and 2/10).
- You have been diagnosed with advanced dry age-related macular degeneration (AMD).
- You are willing to follow the study procedures and sign a consent form.
- You do not have other eye diseases causing vision loss, and you are not completely blind or have very mild vision loss.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at something called 'visual frailty' in older adults with advanced age-related macular degeneration (AMD). It aims to develop a tool to better understand how vision loss affects daily life and overall health in people aged 60 and over.
This study tests whether low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. The therapy is a painless light treatment that you might receive in multiple sessions, and the study aims to see if it can slow or improve vision decline.
This study looks at how different types of lighting (like bright or dim lights) affect your ability to see if you have dry AMD. The goal is to find lighting conditions that help you see better, which could improve your daily life.
This study tests a new treatment to improve vision in people with advanced age-related macular degeneration (AMD). If you have significant vision loss from AMD, this might help you see better.
This study looks at how age-related macular degeneration (AMD) affects the light-sensitive part of the eye (retina) and the brain. By joining, you help researchers learn more about the condition, which could lead to better treatments in the future.
This study tests whether virtual reality tests can measure vision problems caused by age-related macular degeneration (AMD). It includes people with different stages of AMD, from early to advanced, as well as healthy adults, to see how well the tests work for each group.
Hear when a new Anxiety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.